Immediate Impact
1 by Nobel laureates 51 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2025 Standout
Works of Hideki Miyata being referenced
Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Hideki Miyata | 280 | 276 | 139 | 163 | 35 | 573 | |
| Chisato Saeki | 233 | 215 | 132 | 226 | 47 | 601 | |
| Yuichi Torisu | 190 | 125 | 108 | 196 | 50 | 562 | |
| Takumi Akiyama | 262 | 240 | 116 | 81 | 25 | 516 | |
| Endrit Shahini | 208 | 144 | 72 | 92 | 48 | 462 | |
| Kazuhiro Katayama | 173 | 190 | 134 | 44 | 32 | 528 | |
| Yona Kitay‐Cohen | 238 | 196 | 58 | 146 | 44 | 575 | |
| Hideomi Tomida | 200 | 174 | 83 | 79 | 33 | 572 | |
| Kazunori Ishige | 235 | 119 | 133 | 118 | 34 | 628 | |
| Jörg Arend | 207 | 263 | 88 | 95 | 28 | 627 | |
| Carsten Meyer | 336 | 363 | 58 | 82 | 21 | 526 |
All Works
Login with ORCID to disown or claim papers
Loading papers...